[Clinical significance of targeting drug-based molecular biomarkers expression in ovarian clear cell carcinoma].

Li, M J; Li, H R; Cheng, X; Bi, R; Tu, X Y; Liu, F; Chen, L H

Li, M J; Li, H R; Cheng, X; Bi, R; Tu, X Y; Liu, F; Chen, L H.

Affiliation

Li MJ; Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

Zhonghua Fu Chan Ke Za Zhi ; 52(12): 835-843, 2017 Dec 25.

Article in Zh | MEDLINE | ID: mdl-29325268

Subject(s)

Adenocarcinoma, Clear Cell/drug therapy; Adenocarcinoma, Clear Cell/metabolism; Biomarkers, Tumor/metabolism; Neoplasms, Glandular and Epithelial/drug therapy; Neoplasms, Glandular and Epithelial/metabolism; Ovarian Neoplasms/drug therapy; Ovarian Neoplasms/metabolism; Precision Medicine; Adenocarcinoma, Clear Cell/diagnosis; Adenocarcinoma, Clear Cell/mortality; BRCA2 Protein; Carcinoma, Ovarian Epithelial; China; Disease-Free Survival; ErbB Receptors; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial/diagnosis; Neoplasms, Glandular and Epithelial/mortality; Ovarian Neoplasms/diagnosis; Ovarian Neoplasms/mortality; Receptor, ErbB-2; Survival Analysis; Treatment Outcome

Key words

Adenocarcinoma, clear cell; Aurora kinase A; Ovarian neoplasms; Receptor, erbB-2; Tumor markers, biological

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Biomarkers, Tumor / Adenocarcinoma, Clear Cell / Neoplasms, Glandular and Epithelial / Precision Medicine Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: Asia Language: Zh Journal: Zhonghua Fu Chan Ke Za Zhi Year: 2017 Document type: Article

Fulltext

XML

PubMed Links

Search on Google